WHAT ANIMAL STUDIES TELL US ABOUT QUERCETIN, VITAMINS C AND D3, CURCUMIN, IVERMECTIN AND FENBENDAZOLE

Genuine anticancer effects in lab and animal studies have been shown in several common use compounds — the antiparasitic drugs Ivermectin and Fenbendazole, the plant flavonoid Quercetin, Vitamins C and D3, and Curcumin (the active ingredient in turmeric).

Each works through a different mechanism:

Ivermectin and Fenbendazole disrupt fundamental processes inside cancer cells that the cells need to survive and divide; According to the NIH, about 250 million to over 500 million people take ivermectin globally each year for neglected tropical diseases. And veterinary treatments exceed 1.5 billion animals globally each year across major livestock and companion species. 

Quercetin reduces inflammation and directly slows cancer cell growth; high-dose Vitamin C creates a toxic oxidative environment specifically inside cancer cells;

Vitamin D3 helps regulate how cells grow and differentiate (preventing the uncontrolled growth that defines cancer); and

Curcumin interferes with multiple chemical signaling pathways that cancers rely on. None of these are new or exotic — they are cheap, widely available, and their safety profiles are already well understood.

The repurposing of these compounds carries potential advantages that justify further exploration. Since the safety and pharmacokinetic profiles of these substances are well-known, their development could be beneficial for animals. Furthermore, the successful repurposing of these compounds could provide a cost-effective way to expand anticancer treatments, possibly improving outcomes in animals.

Disclaimer

This information is for educational purposes only and is not intended to replace the advice of a qualified veterinarian. These statements have not been evaluated by the Food and Drug Administration. 

Virex Health/Virogex Inc.